long-acting insulin


Also found in: Dictionary, Thesaurus, Encyclopedia.

long-acting insulin

a preparation of insulin modified by an interaction with zinc under specific chemical conditions and supplied as a suspension with a prolonged action. An injection of the preparation takes effect within 8 hours, reaches a peak of action in 16 to 24 hours, and has a duration of action of more than 36 hours. Also called slow-acting insulin, ultralente insulin. Compare intermediate-acting insulin, short-acting insulin. See also insulin.
References in periodicals archive ?
Ryzodeg 70/30 is a mixture of insulin degludec, a long-acting insulin analog, and insulin aspart, a rapid-acting human insulin analog.
The modified insulin was able to give more appropriate control of blood sugar than the unmodified insulin or the long-acting insulin," Anderson says.
agreed that IDeg addressed the need for a long-acting insulin.
It is usually prescribed for adults with type 2 diabetes and adults and children (aged six and above) with type 1 diabetes who require long-acting insulin for the control of high blood sugar.
The use of long-acting insulin formulations (NPH or glargine) increased from 31% to 57%, and the use of mealtime insulin from 28% to 58%.
10) Currently, two rapid-acting insulin analogs, insulin lispro and insulin aspart, and one long-acting insulin analog, insulin glargine, are available (Fig.
Until enough data are available to eliminate concerns about potential immunogenicity with the new long-acting insulin analogue glargine (Lantus), basal insulin needs during pregnancy should be delivered with either lispro or aspart in an insulin infusion pump or with the use of two or three injections a day of NPH insulin, she said at the annual meeting of the North American Diabetes in Pregnancy Study Group.
About Toujeo Prescription Toujeo is a long-acting insulin used to treat adults with type 2 and type 1 diabetes for the control of high blood sugar.
regulatory submission for our new insulin glargine product demonstrates our progress in bringing another option to the millions of Americans with diabetes who require long-acting insulin as an integral part of their treatment plan," said Gwen Krivi, Ph.
A new indication for fixed-dose exenatide injections has been approved as an add-on therapy to insulin glargine, with or without metformin and/or a thiazolidinedione, for adults with type 2 diabetes who are not achieving adequate glycemic control on long-acting insulin alone.
These women typically have enough pancreatic function that long-acting insulin need be added only in the third trimester.